AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...
AstraZeneca has breached the UK pharma industry's code of practice with a claim on its website for asthma drug Symbicort, ...
Harvard Pilgrim Health Care has entered into its third outcomes-based pharmaceutical contract tying what it pays for drugs to how well the patient does on the medicine. In its most recent agreement, ...
President Donald Trump announced on Friday a deal with drugmaker AstraZeneca in his latest effort to lower drug costs through ...
LONDON, Oct 18 (Reuters) - AstraZeneca Plc lost a key European patent on its two-in-one asthma drug Symbicort on Thursday but the drugmaker said it did not expect the move to have an immediate impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback